Controversy surrounding aducanumab for Alzheimer’s disease

LI Wenkai

PDF(354 KB)
  • ISSN 2096-5516 CN 10-1536/R
  • Sponsored: China Association for Alzheimer’s Disease
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2020, Vol. 3 ›› Issue (1) : 61-64. DOI: 10.3969/j.issn.2096-5516.2020.01.015

Controversy surrounding aducanumab for Alzheimer’s disease

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 3(1): 61-64 https://doi.org/10.3969/j.issn.2096-5516.2020.01.015

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(354 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉